Merck (MRK)
$90.97
0.39 (0.43%)
MRK Stock Quote Delayed 30 Minutes
27 Biotechnology Stocks to Sell Now
This week, 27 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$89.38
Market Cap
229.13B
PE Ratio
13.50
EPS
6.7363
Volume (Avg. Vol.)
10.21M
Day's Range
$89.25 - $90.97
52-Week Range
$81.04 - $132.70
Dividend & Yield
$3.12 (3.43%)
MRK Stock Predictions, Articles, and Merck News
Nothing Can Stop Merck & Co., Inc. (MRK) Stock Now
MRK stock will likely continue its rise. This is supported by Merck & Co.'s momentum and first-place position in the appealing IO industry.
BMY Stock: Don’t Try to Catch This Falling Knife … Yet
Bristol-Myers (BMY) stock is a hot mess right now, but it still has long-term value in its cancer drug pipeline.
Trade of the Day: Buy Merck & Co., Inc. (MRK) … But Not Yet
While Merck looks like it will be rewarding shareholders well in the future, the price of MRK stock is just a little too high right now.
Hottest Manufacturing Stocks Now – LTEA LCUT SYUT SYNL
The following stocks were moving the Manufacturing sector today.
Gilead Sciences, Inc. Is More Than an HCV Play (GILD)
Gilead Sciences (GILD) stock is a bargain at these prices. Traders just have yet to see the glass as half full.
3 Stocks to Watch Monday: Mylan NV (MYL), Bristol-Myers Squibb Co (BMY) and Comcast Corporation (CMCSA)
Mylan (MYL) is bouncing back to life on an Epipen settlement, Bristol-Myers Squibb (BMY) is getting hit again on Opdivo disappointment and everyone still hates Comcast (CMCSA).
10 Pharmaceuticals Stocks to Buy Now
10 Pharmaceuticals stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
FDA Issues Warning on Hepatitis C Drugs
The Food and Drug Administration (FDA) has issued a warning surrounding several Hepatitis C drugs such as Sovaldi, Harvoni and Gilead Sciences.
11 Pharmaceuticals Stocks to Buy Now
The grades of 11 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Biggest Movers in Manufacturing Stocks Now – MRUS AUPH NMBL TCON
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Sanofi SA (ADR) (SNY) Sues Merck & Co., Inc. (MRK) Over Multiple Patent Infringements
Sanofi (SNY) is suing Merck (MRK) for what it claims are several instances of patent infringement connected to its diabetes drug Lantus.
6 Semiconductors & Semiconductor Equipment Stocks to Sell Now
This week, 6 Semiconductors & Semiconductor Equipment stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Merck & Co., Inc. Features Slow and Steady Dividend Growth (MRK)
Merck is a blue-chip dividend stock that may be a solid investment, however MRK's dividend growth lags other competitors
Merck & Co., Inc. (MRK) Preps for a Healthy Breakout
The price action in Merck is mega-bullish and that means there are some cheap ways to try for big rewards in MRK stock.
